Who invested in Alebund Pharmaceuticals?
Alebund Pharmaceuticals's investors include Lilly Asia Ventures, Huagai Capital and Sherpa Healthcare Partners.
Who invested in Alebund Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$75Mraised across 1 round since 2025, from 1 source
- Latest round
- Series C, $75MJan 2025
- Investors
- 3
The rounds
- Jan 2025
Everyone who backed them
Lilly Asia VenturesVC firm1round
Sherpa Healthcare PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Alebund Pharmaceuticals
How much has Alebund Pharmaceuticals raised?
Alebund Pharmaceuticals has raised $75M across 1 round since 2025.
When did Alebund Pharmaceuticals last raise?
Alebund Pharmaceuticals's most recent round was a Series C of $75M in Jan 2025.
What was Alebund Pharmaceuticals's biggest round?
Its most recent round, $75M in Jan 2025, is also its largest on record.
Who backed Alebund Pharmaceuticals first?
Alebund Pharmaceuticals's first round on record, in Jan 2025, was backed by Lilly Asia Ventures, Huagai Capital and Sherpa Healthcare Partners.
What stage is Alebund Pharmaceuticals at?
Alebund Pharmaceuticals's latest named round is a Series C, in Jan 2025.
Companies like Alebund Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.